Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights August 12, 2022
TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress August 11, 2022
Renovia Receives FDA Clearance for leva® Pelvic Health System as First-line Treatment for Chronic Fecal Incontinence July 11, 2022
TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology July 11, 2022
New Clinical Study Demonstrates Colorescience All Calm® Regimen Neutralizes Redness and Calms Inflamed Skin June 30, 2022
XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy for Ischemic Heart Disease June 30, 2022
